Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Special instructions and independent opinions of independent directors on the company’s external guarantees according to the requirements of regulatory guidelines for listed companies No. 8 – regulatory requirements for capital exchanges and external guarantees of listed companies and other normative documents of the CSRC, as well as the articles of association and other relevant regulations, as independent directors of Sichuan Huiyu Pharmaceutical Co.Ltd(688553) (hereinafter referred to as “the company”), after carefully checking the company’s external guarantees in 2021, Make the following special instructions and independent opinions:
In 2021, the company did not provide external guarantees, nor did it have guarantees in previous years that continued to be performed this year. Therefore, the company does not need to reveal the risks of external guarantee, and will not bear the guarantee liability due to the default of the guaranteed party’s debt.
Independent directors: Wang Ruwei, long Yongqiang, Liang Xinxin
April 6, 2022 (no text below)
(there is no text on this page, which is the signature page of the special instructions and independent opinions of Sichuan Huiyu Pharmaceutical Co.Ltd(688553) independent directors on the company’s external guarantee)
independent director:
Wang Ruwei
Yong Qiang Long
Liang Xinxin
April 6, 2022
